Harvard Bioscience Stock Shares Owned By Insiders
| HBIO Stock | USD 3.18 0.02 0.63% |
Harvard Bioscience fundamentals help investors to digest information that contributes to Harvard Bioscience's financial success or failures. It also enables traders to predict the movement of Harvard Stock. The fundamental analysis module provides a way to measure Harvard Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harvard Bioscience stock.
Harvard | Shares Owned By Insiders |
Harvard Bioscience Company Shares Owned By Insiders Analysis
Harvard Bioscience's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Harvard Bioscience Shares Owned By Insiders | 7.73 % |
Most of Harvard Bioscience's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harvard Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Harvard Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Harvard Bioscience is extremely important. It helps to project a fair market value of Harvard Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Harvard Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Harvard Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Harvard Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 7.731% of Harvard Bioscience are shares owned by insiders. This is 49.07% lower than that of the Life Sciences Tools & Services sector and 50.76% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 23.38% higher than that of the company.
Harvard Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harvard Bioscience's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harvard Bioscience could also be used in its relative valuation, which is a method of valuing Harvard Bioscience by comparing valuation metrics of similar companies.Harvard Bioscience is currently under evaluation in shares owned by insiders category among related companies.
Harvard Bioscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Harvard Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Harvard Bioscience's managers, analysts, and investors.Environmental | Governance | Social |
Harvard Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0069 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 175.22 M | ||||
| Shares Outstanding | 43.43 M | ||||
| Shares Owned By Insiders | 7.73 % | ||||
| Shares Owned By Institutions | 77.01 % | ||||
| Number Of Shares Shorted | 620.05 K | ||||
| Price To Earning | (25.00) X | ||||
| Price To Book | 2.53 X | ||||
| Price To Sales | 1.64 X | ||||
| Revenue | 112.25 M | ||||
| Gross Profit | 62.29 M | ||||
| EBITDA | 9.28 M | ||||
| Net Income | (3.42 M) | ||||
| Cash And Equivalents | 4.26 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 42.77 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 2.42 X | ||||
| Book Value Per Share | 1.58 X | ||||
| Cash Flow From Operations | 14.03 M | ||||
| Short Ratio | 6.00 X | ||||
| Earnings Per Share | (0.20) X | ||||
| Price To Earnings To Growth | 2.89 X | ||||
| Target Price | 6.92 | ||||
| Number Of Employees | 391 | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 138.11 M | ||||
| Total Asset | 137.37 M | ||||
| Retained Earnings | (145.6 M) | ||||
| Working Capital | 22.5 M | ||||
| Current Asset | 50.55 M | ||||
| Current Liabilities | 19.32 M | ||||
| Net Asset | 137.37 M |
About Harvard Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harvard Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harvard Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harvard Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harvard Bioscience Piotroski F Score and Harvard Bioscience Altman Z Score analysis. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Harvard Stock analysis
When running Harvard Bioscience's price analysis, check to measure Harvard Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harvard Bioscience is operating at the current time. Most of Harvard Bioscience's value examination focuses on studying past and present price action to predict the probability of Harvard Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harvard Bioscience's price. Additionally, you may evaluate how the addition of Harvard Bioscience to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Harvard Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.20) | Revenue Per Share 2.498 | Quarterly Revenue Growth (0.18) | Return On Assets (0.01) |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.